It is currently Thu Oct 30, 2014 6:04 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Synthetic Estrogen/Progestin Risk Info

A long time ago I indicated I would post some info on the risks of estrogen and progesterone in postmenopausal women. Sorry it's taken so long but finally here’s some information for women who may be considering hormone replacement therapy.

The most recent research found that synthetic estrogen (taken without synthetic progesterone) does not increase the risk of breast cancer. There’s also a hint, consistent with research I’ve read, that the risky culprit in hormone ...
Read more : Synthetic Estrogen/Progestin Risk Info | Views : 3736 | Replies : 1 | Forum : MS in the Golden Years


I have Lyme Disease, but not well since Adult Chicken Pox

8) Hi, This is my 1st post. It was March '92, Senior yr. in College, & I got the Adult Chicken-Pox after babysitting 5 kids with them...I ASSUMED Iwas safe...you know how that goes! I haven't been well 1 SINGLE DAY SINCE! YIKES!

I have Lyme, HHV 1 & 6 and EBV...My MRI's show Demyelixation from Chronic Lyme Disease.

Any Thoughts?

Thanx A Million~Blue Eyes
Read more : I have Lyme Disease, but not well since Adult Chicken Pox | Views : 1342 | Replies : 2 | Forum : General Discussion


BHT-3009 Phase II trial begins dosing

Bayhill doses patients with multiple sclerosis in phase II trial, raises $15.8M

Science Letter - May. 12, 2006

Bayhill Therapeutics, Inc., has begun dosing patients with BHT-3009, the company's experimental drug candidate, in a phase II company sponsored trial for multiple sclerosis.

The phase II study is a multicenter, double-blind, placebo-controlled evaluation with an MRI endpoint. In a related development, current investors indicated strong support for Bayhill's antigen-specific tolerance platform by raising an additional $15.8 ...
Read more : BHT-3009 Phase II trial begins dosing | Views : 1135 | Replies : 0 | Forum : Drug Pipeline


When is enough, enough?

Dear all,

The BBC ran the story below as part of the MS Awareness week. I've only had this disease 2 years (dxed two years ago - no symptoms before) - but this story is not a pleasant read. I'm just not sure how typical this story is - you see these terms 'late stage MS', 'end stage MS' but I'm not sure what this actually mean. They tell us that we can expect to ...
Read more : When is enough, enough? | Views : 2083 | Replies : 14 | Forum : General Discussion


Diet and Supplements in MS: A Reasonable Approach

Diet and Supplements in MS: A Reasonable Approach

In some respects, the role of diet and dietary supplements in multiple sclerosis (MS) is controversial. The most conservative, mainstream approach purports that, because the evidence is inconclusive, dietary strategies should not play a significant part in MS treatment plans. At the other end of the spectrum, some have claimed that a particular diet or supplement can cure the disease.


“Both views are overstated and are not ...
Read more : Diet and Supplements in MS: A Reasonable Approach | Views : 1910 | Replies : 6 | Forum : General Discussion


IL-23

This seems too early for the pipeline even...



Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

J Clin Invest. 2006 May 1;116(5):1317-1326.
Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ.
Discovery Research, Schering-Plough Biopharma, Palo Alto, California, USA. Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Experimental Pathology and Pharmacology ...
Read more : IL-23 | Views : 885 | Replies : 0 | Forum : General Discussion


Phase III Trial of Oral Cladribine Starts

Phase III Trial of Oral Cladribine, a Novel Investigational Therapy for Multiple Sclerosis, Begins in the United States
Thursday May 4, 8:17 am ET
Nationwide Recruitment Begins at Sites Across the U.S.

ROCKLAND, Mass. and GENEVA, May 4 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) announced today that recruitment in the U.S. is beginning for the Phase III CLARITY study (CLAdRIbine Tablets in Treating MS OrallY Study) of oral cladribine for the treatment of ...
Read more : Phase III Trial of Oral Cladribine Starts | Views : 1934 | Replies : 6 | Forum : Drug Pipeline


Twenty-three and onward

It is several months since my last post. This is a short update for those who are interested in how antibiotics return to some people lives that were thought lost for always.

In Sept., 2004 I was very dim and fading fast when my sister found the work of David Wheldon and Charles Stratton based on the cause of MS as a bacterium of the Chlamydia family, a nasty, devious bug not even discovered until ...
Read more : Twenty-three and onward | Views : 2504 | Replies : 6 | Forum : Regimens


Restless Leg Syndrome

Not specifically for MS but may help for those with RLS.

http://news.bbc.co.uk/1/hi/health/4969870.stm
Read more : Restless Leg Syndrome | Views : 992 | Replies : 0 | Forum : General Discussion


Itching

Does anyone else have itching as a symptom? I had it for a short time last summer and now for the last two months, not just in my extremities but every where. I am currently taking Lyrica, Baclofen and Amitriptiline. I have phased out Neurontin and I am working on lowering my Lyrica dose. I was at 75mg twice a day, now 25mg twice a day. Not looking for free medical advice, so any help ...
Read more : Itching | Views : 1900 | Replies : 8 | Forum : General Discussion


 

Login  •  Register


Statistics

Total posts 220978 • Total topics 22910 • Total members 14474


Contact us | Terms of Service